Skip to main content

Find Clinical Trials

Home
Conditions
Patients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLC

Clinical trial condition

Patients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLC

Explore clinical trials studying Patients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLC. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Patients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLC trial results

Recruiting

Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort Study

NCT07696832

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

View Trial Details